PMID- 25504281 OWN - NLM STAT- MEDLINE DCOM- 20150824 LR - 20171221 IS - 1526-2359 (Electronic) IS - 1073-2748 (Linking) VI - 22 IP - 1 DP - 2015 Jan TI - Using HLA typing to support patients with cancer. PG - 79-86 AB - BACKGROUND: The human leukocyte antigen (HLA) system plays a crucial role in immune function, and HLA testing is often needed in the support of patients with cancer. METHODS: We briefly review the published literature to clarify the nomenclature of the HLA system, currently available methods for HLA testing, and commonly used HLA assays. The uses of HLA testing in pharmacogenomics, disease association, platelet transfusion support, and in the management of both solid organ and hematopoietic stem cell transplantation are also reviewed. RESULTS: HLA testing is commonly performed for select patient populations, including patients with cancer and in those requiring solid organ and hematopoietic stem cell transplantation. CONCLUSION: Newer molecular typing methods have helped improve patient outcomes following hematopoietic stem cell transplantation. FAU - Fung, Mark K AU - Fung MK AD - Department of Pathology, Blood Bank and HLA Laboratory, University of Vermont Medical Center, Burlington, 05401, USA. Mark.Fung@vtmednet.org. FAU - Benson, Kaaron AU - Benson K LA - eng PT - Journal Article PT - Review PL - United States TA - Cancer Control JT - Cancer control : journal of the Moffitt Cancer Center JID - 9438457 RN - 0 (HLA Antigens) SB - IM MH - HLA Antigens/*classification/*genetics MH - Hematopoietic Stem Cell Transplantation MH - Histocompatibility Testing/*methods MH - Humans MH - Neoplasms/*therapy MH - Organ Transplantation MH - Platelet Transfusion EDAT- 2014/12/17 06:00 MHDA- 2015/08/25 06:00 CRDT- 2014/12/16 06:00 PHST- 2014/12/16 06:00 [entrez] PHST- 2014/12/17 06:00 [pubmed] PHST- 2015/08/25 06:00 [medline] AID - 10.1177/107327481502200110 [doi] PST - ppublish SO - Cancer Control. 2015 Jan;22(1):79-86. doi: 10.1177/107327481502200110.